Towards accurate indel calling for oncopanel sequencing through an international pipeline competition at precisionFDA

Towards accurate indel calling for oncopanel sequencing through an international pipeline competition at precisionFDA

Abstract Accurately calling indels with next-generation sequencing (NGS) data is critical for clinical application. The precisionFDA team collaborated with the U.S. Food and Drug Administration’s (FDA’s) National Center for Toxicological Research (NCTR) and successfully completed the NCTR Indel Call...

Full description

Bibliographic Details
Main Authors: Binsheng Gong, Samir Lababidi, Rebecca Kusko, Khaled Bouri, Sarah Prezek, Vishal Thovarai, Anish Prasanna, Ezekiel J. Maier, Mahdi Golkaram, Xingqiang Sun, Konstantinos Kyriakidis, João Paulo Kitajima, Sayed Mohammad Ebrahim Sahraeian, Yunfei Guo, Elaine Johanson, Wendell Jones, Weida Tong, Joshua Xu
Format: Article
Language:English
Published: Nature Portfolio 2024-04-01
Series:Scientific Reports
Subjects:
Indel calling pipeline
Next-generation sequencing
Precision medicine
Personalized medicine
precisionFDA challenge
Online Access:https://doi.org/10.1038/s41598-024-58573-y

Internet

https://doi.org/10.1038/s41598-024-58573-y

Similar Items